Predicting clinical response to costimulation blockade in autoimmunity.

Predicting clinical response to costimulation blockade in autoimmunity.
复制标题

DOI:
10.1093/immadv/ltaa003
复制
发表时间:
2021-01
影响因子:
--
通讯作者:
Walker LSK
Walker LSK
中科院分区:
其他
文献类型:
--
作者:
Edner NM;Wang CJ;Petersone L;Walker LSK

文献摘要

参考文献

被引文献

相似文献

在过去 15 年里,通过共刺激阻断来抑制不需要的 T 细胞反应已成为公认的免疫抑制策略。然而,我们对如何最好地部署这种干预措施的理解仍在不断发展。一个关键的挑战是对共刺激阻断的临床反应的异质性,以及无法预测哪些个体可能受益最大。在这里,我们讨论了基于对 1 型糖尿病 (T1D) 患者使用共刺激阻断的最新发现,并将其置于当前文献的背景下。我们讨论了治疗前血液样本中滤泡辅助 T 细胞 (Tfh) 的分析如何有助于预测哪些个体可能受益于阿巴西普等共刺激阻断药物。
Curbing unwanted T cell responses by costimulation blockade has been a recognised immunosuppressive strategy for the last 15 years. However, our understanding of how best to deploy this intervention is still evolving. A key challenge has been the heterogeneity in the clinical response to costimulation blockade, and an inability to predict which individuals are likely to benefit most. Here, we discuss our recent findings based on the use of costimulation blockade in people with type 1 diabetes (T1D) and place them in the context of the current literature. We discuss how profiling follicular helper T cells (Tfh) in pre-treatment blood samples may have value in predicting which individuals are likely to benefit from costimulation blockade drugs such as abatacept.
DOI: 10.2337/db15-1615
发表时间: 2016-05-01
期刊: DIABETES
影响因子: 7.7
作者:
Leete, Pia;Willcox, Abby;Morgan, Noel G.
通讯作者: Morgan, Noel G.
DOI: 10.1136/annrheumdis-2015-207942
发表时间: 2016-04
影响因子: 27.4
作者:
Sokolove J;Schiff M;Fleischmann R;Weinblatt ME;Connolly SE;Johnsen A;Zhu J;Maldonado MA;Patel S;Robinson WH
通讯作者: Robinson WH
DOI: 10.1126/science.1202947
发表时间: 2011-04-29
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Qureshi OS;Zheng Y;Nakamura K;Attridge K;Manzotti C;Schmidt EM;Baker J;Jeffery LE;Kaur S;Briggs Z;Hou TZ;Futter CE;Anderson G;Walker LS;Sansom DM
通讯作者: Sansom DM
DOI: 10.2337/db14-0047
发表时间: 2014-10
期刊: Diabetes
影响因子: 7.7
作者:
Orban T;Beam CA;Xu P;Moore K;Jiang Q;Deng J;Muller S;Gottlieb P;Spain L;Peakman M;Type 1 Diabetes TrialNet Abatacept Study Group
通讯作者: Type 1 Diabetes TrialNet Abatacept Study Group
DOI: 10.1084/jem.190.8.1115
发表时间: 1999-10-18
期刊: The Journal of experimental medicine
影响因子: --
作者:
Walker LS;Gulbranson-Judge A;Flynn S;Brocker T;Raykundalia C;Goodall M;Förster R;Lipp M;Lane P
通讯作者: Lane P